* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Biopharmaceutics / Lec
Survey
Document related concepts
Psychopharmacology wikipedia , lookup
Orphan drug wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Compounding wikipedia , lookup
Neuropharmacology wikipedia , lookup
List of comic book drugs wikipedia , lookup
Plateau principle wikipedia , lookup
Pharmacognosy wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Theralizumab wikipedia , lookup
Prescription costs wikipedia , lookup
Drug design wikipedia , lookup
Drug discovery wikipedia , lookup
Transcript
Biopharmaceutics / Lec: 1 Biopharmaceutics: Dr . Ghufran Mohammad is the science that examines the interrelationship of the physicochemical properties of the drug, the dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption. Thus Biopharmaceutics involves factors that influence: 1. The stability of the drug within the product. 2. The rate of drug release from the product. 3. The rate of dissolution of the drug at the absorption site. 4.The availability of the drug at its site of action (the systemic absorption of the drug). The goal of biopharmaceutical studies is to develop a dosage form that will provide consistent bioavailability at a desirable rate. These studies must be able to assess the impact of the physical and chemical properties of the drug, drug stability, and large-scale production of the drug product on the biologic performance of the drug. Moreover, Biopharmaceutics considers the properties of the drug and dosage form in a physiologic environment, the drug's intended therapeutic use, and the route of administration. Thus the study of Biopharmaceutics allows the pharmacist to design drug products rationally to deliver the active drug at a specific rate and amount into the body to optimize therapeutic effect and to minimize any adverse effects. I Scheme demonstrating the dynamic relationships among the drug, the product, and pharmacologic effect. Pharmacokinetics: The study and characterization of the time course (kinetics) of drug absorption, distribution and elimination (i.e. metabolism and excretion) (ADME). The description of drug distribution and elimination is often termed drug disposition. Absorption: is the process of a substance entering the body. Distribution: is the dispersion of substances throughout the fluids and tissues of the body. Metabolism: is the irreversible transformation of parent compounds into daughter metabolites. Excretion: is the elimination of the substances from the body. Pharmacokinetics is also applied to therapeutic drug monitoring (TDM) for very potent drugs such as those with a narrow therapeutic range, in order to optimize efficacy and to prevent any adverse toxicity. For these drugs, it is necessary to monitor the patient, either by monitoring plasma drug concentrations (e.g. theophylline) or by monitoring a specific pharmacodynamic endpoint such as prothrombin clotting time (e.g. warfarin). II Bioavailability: The rate and extent of drug absorption. Bioavailable dose: The fraction of an administered dose of a particular drug that reaches the systemic circulation intact. Plasma level-time curve: The plasma level-time curve is generated by measuring the drug concentration in plasma samples taken at various time intervals after a drug product is administered. The concentration of drug in each plasma sample is plotted against the corresponding time at which the plasma sample was removed. III Drug Product Performance Parameters: 1. Minimum effective concentration (MEC): The minimum concentration of drug needed at the receptors to produce the desired pharmacologic effect. 2. Minimum toxic concentration (MTC): The drug concentration needed to just produce a toxic effect. 3. Onset time: The time required for the drug to reach the MEC. 4. Duration of action: The difference between the onset time and the time for the drug to decline back to the MEC 5. The time of peak plasma level: The time of maximum drug concentration in the plasma and is proportional to the rate of drug absorption. 6. The peak plasma level: The maximum drug concentration, usually related to the dose and the rate constants for absorption and elimination of the drug. 7. Area under the curve: It is related to the amount of drug absorbed systemically. Pharmacokinetic Models Drugs are in a dynamic state within the body as they move between tissues and fluids, bind with plasma or cellular components, or are metabolized. The biologic nature of drug distribution and disposition is complex and such factors must be considered when designing drug therapy regimens. The inherent and infinite complexity of these events require the use of mathematical models and statistics to estimate drug dosing and to predict the time course of drug efficacy for a given dose. Pharmacokinetic models are used to: 1. Predict plasma, tissue, and urine drug levels with any dosage regimen. IV 2. Calculate the optimum dosage regimen for each patient individually. 3. Estimate the possible accumulation of drugs and/or metabolites. 4. Correlate drug concentrations with pharmacologic or toxicologic activity. 5. Evaluate differences in the rate or extent of availability between formulations (bioequivalence). 6. Describe how changes in physiology or disease affect the absorption, distribution, or elimination of the drug. 7. Explain drug interactions. A very simple and useful tool in pharmacokinetics is compartment models. Two parameters are needed to describe model 1: the volume of the compartment and the elimination rate constant, k. In the case of model 4, the pharmacokinetic parameters consist of the volumes of compartments 1 and 2 and the rate constants k a, k, k 12, and k 21. V